CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Children's Oncology Group
Children's Oncology Group
Essen Biotech
Australian & New Zealand Children's Haematology/Oncology Group
Memorial Sloan Kettering Cancer Center
Turning Point Therapeutics, Inc.
Incyte Corporation
Institut Curie
Incyte Corporation
University Hospital, Basel, Switzerland
Bayer
Bristol-Myers Squibb
Shenzhen BinDeBio Ltd.
AHS Cancer Control Alberta
Columbia University
Radiation Therapy Oncology Group
University of Kentucky
Asan Medical Center
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center